dc.contributor.author | Kvist, Beate Charlotte Fagerlund | |
dc.contributor.author | Chudasama, Kishan Kumar | |
dc.contributor.author | Brurberg, Kjetil Gundro | |
dc.contributor.author | Robberstad, Bjarne | |
dc.contributor.author | Rose, Christopher James | |
dc.contributor.author | Juvet, Lene Kristine | |
dc.contributor.author | Fretheim, Atle | |
dc.date.accessioned | 2022-02-21T07:15:21Z | |
dc.date.available | 2022-02-21T07:15:21Z | |
dc.date.created | 2022-02-18T10:28:04Z | |
dc.date.issued | 2019 | |
dc.identifier.isbn | 978-82-8406-020-0 | |
dc.identifier.uri | https://hdl.handle.net/11250/2980345 | |
dc.language.iso | eng | |
dc.publisher | Norwegian Institute of Public Health / Folkehelseinstituttet | |
dc.relation.uri | https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2019/prosigna-gene-signature-to-assess-expected-benefit-from-chemotherapy-in-breast-cancer-rapport-2019-v2.pdf | |
dc.title | Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission | |
dc.title.alternative | Prosigna genprofiltest for å vurdere forventet nytte av kjemoterapi ved brystkreft. Vurdering av innsendt informasjon | |
dc.type | Research report | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 70 | |
dc.identifier.cristin | 2003211 | |
cristin.ispublished | true | |
cristin.fulltext | original | |